http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007147346-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37ee34331195a15ade01e85aa22dee65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d02a003ea30c15a54105e60c7e3c8b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_043dba4c27aa24ddf99358d5cf32c11c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47d1e8a4e6bc195c3ed76a7108671bb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e74277852f1aae0a3ff13f59a65456d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dcb5af1d2406ca88fc66015e9e59c40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20e55dd4e41d7ee864e14ac2678859b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c822370026575e4486b1a8d11d9bea5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_abc9acb3ae61aeda4d549249f61a894f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-10
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-499
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10
filingDate 2007-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf78d883933f0f5d6b56af68b476f2c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84fe9fcc28e2383a295c1b48be216af5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72aadbb9a4bdab9aa7167649f46713f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_272efe42ecd956d65389fad7abf0650f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61f2250670b2019bc1590a7d39b9bd6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7aa4191e460e90017df45c82abdbe79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50b35e6425e869703cb19cf0cc89d033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a329169a377dde4d3e0a20682b2cdb29
publicationDate 2007-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007147346-A1
titleOfInvention Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof
abstract Compounds represented by general formula (I), their stereoisomers, tautomers, derivatives, prodrugs or pharmaceutically accepted salts, and their preparation methods or uses for the manufacture of a medicament of analgesics. In which R1 is selected from H, substituted or unsubstituted phenyl, or substituted or unsubstituted heteroaryl; A selected from bond, or substituted or unsubstituted hydrocarbon radical;R2, R3 each other independently is selected from hydrogen or methyl, which linked with the any position of spiro structure; n and m are integer of 0~2, and do not represent 0 at same time; B, D each other independently is lineared or branched alkylene; Y is selected from –CHR4-, O, S, -S(O)-, -SO2-, -NR4 or substituted or unsubstituted phenylene, in which R4 selected from H, saturated or unsaturated C1-C6-alkyl, substituted or unsubstituted aryl, or heteroaryl substituted methyl or ethyl; X- is pharmaceutically accepted inorganic or organic anion. These compounds can be used as muscarine receptor (M-receptor) and/or nicotine acetylcholine receptor (N-receptor) agonist or antagonist. These compounds have good analgesic effect without side effect such as addiction.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019110006-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102898428-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102898428-B
priorityDate 2006-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226461930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226458662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22032834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66594757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226461931

Total number of triples: 50.